RGEN: Repligen Corporation
今日RGEN汇率已更改-1.19%。当日,交易品种以低点165.00和高点169.50进行交易。
关注Repligen Corporation动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RGEN新闻
- ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
- Software Rebound Extends Moat Index Gains
- Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report?
- TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study
- QURE Submits Application for Gene Therapy for Huntington's Disease
- Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies
- Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?
- GSK to Advance mRNA Influenza Vaccine Into Phase III Development
- OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
- Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
- JAZZ Rises on Updated OS Results From Gastric Cancer Study
- Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
- Why Is Viking Therapeutics (VKTX) Up 2.3% Since Last Earnings Report?
- ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
- Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?
- Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
- 5 Biotech Stocks Worth Adding to Your Portfolio Now
- J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
- GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
- Acadia Gets European Commission Nod for Daybu in Rett Syndrome
- HALO Stock Rises 36% in a Month: Here's What You Should Know
- Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises
- MRK/MRNA's Personalized Cancer Therapy Delivers First Phase III Win
- RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos
常见问题解答
RGEN股票今天的价格是多少?
Repligen Corporation股票今天的定价为167.60。它在165.00 - 169.50范围内交易,昨天的收盘价为169.61,交易量达到1942。RGEN的实时价格图表显示了这些更新。
Repligen Corporation股票是否支付股息?
Repligen Corporation目前的价值为167.60。股息政策取决于公司,而投资者也会关注1.15%和USD。实时查看图表以跟踪RGEN走势。
如何购买RGEN股票?
您可以以167.60的当前价格购买Repligen Corporation股票。订单通常设置在167.60或167.90附近,而1942和1.02%显示市场活动。立即关注RGEN的实时图表更新。
如何投资RGEN股票?
投资Repligen Corporation需要考虑年度范围100.99 - 188.73和当前价格167.60。许多人在以167.60或167.90下订单之前,会比较-6.54%和。实时查看RGEN价格图表,了解每日变化。
Repligen Corporation股票的最高价格是多少?
在过去一年中,Repligen Corporation的最高价格是188.73。在100.99 - 188.73内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Repligen Corporation的绩效。
Repligen Corporation股票的最低价格是多少?
Repligen Corporation(RGEN)的最低价格为100.99。将其与当前的167.60和100.99 - 188.73进行比较,可以发现潜在的长期切入点。观看RGEN在图表上的实时走势以获取更多详细信息。
RGEN股票是什么时候拆分的?
Repligen Corporation历史上曾经历过股票拆分。这些变化在公司行动后的、169.61和1.15%中可见。
- 前一天收盘价
- 169.61
- 开盘价
- 165.90
- 卖价
- 167.60
- 买价
- 167.90
- 最低价
- 165.00
- 最高价
- 169.50
- 交易量
- 1.942 K
- 日变化
- -1.19%
- 月变化
- -6.54%
- 6个月变化
- 41.39%
- 年变化
- 1.15%